Job Description

ROLE SUMMARY

Director, Health Economics & Outcomes Research Immuno-oncology will be a member of the PHI Renal Lung Immuno Oncology (RLIO) team. The focus on Immuno-oncology will be specific to Bavencio in the Globally and in the US for the treatment of Urothelial Cancer, Renal Cell Carcinoma and Merkel Cell Carcinoma and NSCLC. This role will also focus on immuno-oncology pipeline assets.

This role directly impacts the ability to achieve business objectives in the US by providing strategic guidance, executing and communicating evidence generated to demonstrate the value of the approved uses of Bavencio.

The Health Economics & Outcomes Research (HEOR) Director will work in a closely aligned fashion with the Global Medical Affairs, an Alliance partner, and the Cross -Functional Leadership Team (CFLT) and other functional areas within PHI as well as the brand team to ensure there is a single and coordinated view on strategy and delivery from PHI to Bavencio stakeholders.

ROLE RESPONSIBILITIES

* Lead development of the HEOR strategy to support the value of assets in the RLIO portfolio.
* Lead the execution of clinically relevant and scientifically valid, cutting edge HEOR studies and projects (including non-interventional studies, registries, etc.) in alignment with the global HEOR strategy catered to diverse stakeholders (regulators, payers, patients, physicians and policy makers).
* Incorporate relevant patient centric and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence in line with overall medical strategy & access targets for the asset(s).
* Provide strategic input in the selection of relevant patient population, comparators and PRO measures within clinical trials to enable demonstration of robust incremental clinical value over standard of care that can facilitate optimal patient access.
* Selection, related analyses, interpretation and communication of clinical and economic analysis as appropriate for clinical trials, registries, and prospective real world studies.
* Lead the timely development and preparations for committee review of core deliverables such value dossiers (GVDs, AMCP), economic models, and innovative tools to successfully support access.
* Lead the coordination of input from Pfizer and alliance cross-functional colleagues on evidence needs and ensure that the input is appropriately incorporated to support demonstration of product value and optimize patient access.
* Develop real world evidence generation strategies and execute studies (e.g. treatment patterns, burden of illness studies, comparative effectiveness research etc) to generate evidence to support brand competitive differentiation and value proposition.
* Collaborate with Pfizer Country Health & Value teams, conduct training on economic models and updates throughout the product life cycle.
* Lead the development of appropriate data dissemination plans and communicate in a timely manner evidence generated to various stakeholders via publications and conference presentations.
* Optimal project Budget management.

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

* Minimum: Masters degree (MSc, MPH) in health services research, pharmacy administration/pharmaceutical policy, public health, epidemiology, or health economics with a preferred Doctoral degree (PhD, DrPH, ScD) in pharmaceutical administration/ pharmaceutical policy, health services research, public health, epidemiology, or health economics.
* Minimum 8 years experience in health outcomes and related fields, 5 of which are as part of country/global health economics and/or outcomes research teams in a global pharmaceutical company.
* Knowledge and experience in the oncology therapeutic area is preferred.
* Experience working in an alliance preferred.
* Strong working knowledge of the technical and methodological aspects of clinical trial and real world study design and implementation.
* Demonstrated capability independently managing diverse projects ranging from economic analyses, patient reported outcomes to real world database studies.
* Experience with regulatory submissions and interactions with regulatory authorities is desirable.
* Global/ US launch experience is desirable.
* In depth understanding of Pharmacoeconomics and psychometrics/patient reported outcomes is required.
* Knowledge of health care systems and reimbursement processes in key markets and experience with HTA organizations such as CADTH, NICE, HAS, SMC, IQWIG/G-BA, PBAC is desirable.
* Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers and influence in a matrix environment.
* Excellent oral and written English communication skills required.
* Strong publication record is desirable.
* Strong project management abilities (contracting, budgeting, vendor management) essential.
* Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities.
* Demonstrated ability to influence key members of medical and commercial teams constructively and without conflict in a matrix environment.
* Skilled in functioning within a matrix organization where managing through influence is required.

Other Job Details:

Last Date to Apply for Job: April 7th, 2021

Additional Location Information: New York, NY; Collegeville, PA; Groton, CT; US - Remote

LI-PFE

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Market Access

LI-PFE